HMGB1 and peripheral arterial disease: In this study we have evaluated the association between serum HMGB-1 levels and cardiovascular outcomes after LER in a cohort of diabetic patients with PAD and CLTI, showing an association between higher serum HMGB-1 levels and MACE and MALE during the follow-up period after revascularization.